OPIATE RECEPTOR PHARMACOLOGY
OPIATE RECEPTOR PHARMACOLOGY
批准号:
2756682
负责人:
GAVRIL W PASTERNAK
金额:
$9.72万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-01 至 2004-07-31
关键词:
analgesia antisense nucleic acid chemical binding cyclic AMP drug tolerance glucuronides heroin laboratory mouse laboratory rat molecular cloning molecular site morphine narcotic antagonists neuropharmacology nitric oxide opiate alkaloid opioid receptor pharmacogenetics protein isoforms protein protein interaction protein structure function receptor binding receptor expression second messengers tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Opiates are important for the treatment of pain, but their abuse presents a major health proglem. Understanding opioid actions is crucial to their rational use clinically and the development of potential treatments for abuse. Opiates and the opioid peptides act through a family of receptors, of which a number have been cloned. Studies on the actions of these receptors carried out in tissue culture have provided important information regarding their biochemistry. However, these advances now need to be taken into behavioral systems. Recent work using antisense approaches has confirmed the importance of the cloned opioid receptors in opioid pharmacology. Antisense techniques can be used to selectively target individual exons, permitting the examination of splice variants. Using this antisense mapping approach against the MOR-1 clone, which encodes a mu receptor, we found different selectivity profiles for morphine and its extremely potent metabolite morphine-6beta-glucuronide (M6G), implying that they act through distinct receptors. This has now been confirmed in MOR-1 knockout mice. These animals are insensitive to morphine, but retain their sensitivity to M6G. The importance of this M6G receptor is enhanced by the additional observations that heroin and several highly potent clinical analgesics also act through the M6G receptor. Despite the inactivity of morphine in the knockout mice, heroin retains its full analgesic activity. Thus, the M6G receptor might be considered a new heroin receptor. This concept provides important insights into future studies of the mu opioid system. Another member of the opioid receptor family has also proven very interesting. The orphan opioid receptor has led to the identification of a new series of peptides termed orphanin FQ or nociceptin. These agents have a complex pharmacology which will be explored in further detail. Finally, prior work has established that the sigma receptor activates a potent anti-opioid system within the central nervous system. This system is responsible for variations in analgesic sensitivity among some species. We recently cloned the murine sigma receptor and plan to utilize it to gain a better understanding at the molecular level of this system through antisense and other approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2116182
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:7478790
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2458335
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:6378250
-
项目类别:
-
资助金额:$11.86万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:7106618
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2116181
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:6655514
-
项目类别:
-
资助金额:$11.86万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:6925411
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:6174506
-
项目类别:
-
资助金额:$11.86万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:6773089
-
项目类别:
-
资助金额:$12.17万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2116180
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2749018
-
项目类别:
-
资助金额:$9.99万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:6523152
-
项目类别:
-
资助金额:$11.86万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:7269932
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPES
-
批准号:2119575
-
项目类别:
-
资助金额:$16.67万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPES
-
批准号:6378513
-
项目类别:
-
资助金额:$29.48万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPES
-
批准号:3213918
-
项目类别:
-
资助金额:$14.77万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Pharmacology of opioid receptor subtypes
-
批准号:7229520
-
项目类别:
-
资助金额:$39.47万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPES
-
批准号:6515455
-
项目类别:
-
资助金额:$30.37万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Pharmacology of opioid receptor subtype
-
批准号:8261940
-
项目类别:
-
资助金额:$43.98万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
海外基金